Clinical Utilization of Generic Drugs and Biosimilars for Ulcerative Colitis Treatment: Insights from a Nationwide Database Study in Japan
Introduction: Limited data exist regarding the prevalence and clinical practice involving generic drugs and biosimilars for treating ulcerative colitis (UC) in Japan. We aimed to clarify the clinical usage of these generic drugs and biosimilars for UC treatment in Japan using a nationwide database....
Main Authors: | Rintaro Moroi, Yoichi Kakuta, Hiroshi Nagai, Yusuke Shimoyama, Takeo Naito, Hisashi Shiga, Yoshitaka Kinouchi, Atsushi Masamune |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-01-01
|
Series: | Inflammatory Intestinal Diseases |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/536146 |
Similar Items
-
Clinical practice and outcome of patients with elderly‐onset ulcerative colitis: Insights from a nationwide claims database study in Japan
by: Rintaro Moroi, et al.
Published: (2024-06-01) -
Generic and biosimilar medicines: quid?
by: Steven Simoens
Published: (2012-12-01) -
Long‐term prognosis and clinical practice for new‐onset ulcerative colitis in the era of biologics: A Japanese retrospective study
by: Rintaro Moroi, et al.
Published: (2023-10-01) -
Depression is associated with increased disease activity in patients with ulcerative colitis: A propensity score‐matched analysis using a nationwide database in Japan
by: Hideaki Oyama, et al.
Published: (2022-12-01) -
The Impact of Concomitant Ulcerative Colitis on the Clinical Course in Patients with Primary Sclerosing Cholangitis: An Investigation Using a Nationwide Database in Japan
by: Rintaro Moroi, et al.
Published: (2023-02-01)